Alfred D. Kingsley's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 30,000 Common Stock, no par value done at an average price of $0.2 . Disclosure was reported to the exchange on June 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Purchase of securities on an exchange or from another person at price $ 0.21 per share. | 14 Jun 2023 | 30,000 | 469,111 (0%) | 0% | 0.2 | 6,447 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Purchase of securities on an exchange or from another person at price $ 0.28 per share. | 22 Dec 2022 | 25,000 | 439,111 (0%) | 0% | 0.3 | 7,125 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 10,000 | 404,111 (0%) | 0% | 0 | Common Stock, no par value | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 15 Aug 2022 | 5,000 | 409,111 (0%) | 0% | 1.0 | 4,850 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 15 Aug 2022 | 5,000 | 414,111 (0%) | 0% | 1.0 | 4,850 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 394,111 (0%) | 0% | 0 | Common Stock, no par value | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.34 per share. | 23 Dec 2020 | 65,271 | 384,111 (0%) | 0% | 1.3 | 87,463 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2020 | 65,271 | 0 | - | - | Option to purchase common stock | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2020 | 1,237 | 65,271 | - | - | Option to purchase common stock | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.34 per share. | 23 Dec 2020 | 1,237 | 319,740 (0%) | 0% | 1.3 | 1,658 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 23 Dec 2020 | 900 | 318,840 (0%) | 0% | 2.6 | 2,295 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.34 per share. | 21 Dec 2020 | 47,976 | 350,787 (0%) | 0% | 1.3 | 64,288 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 47,976 | 77,024 | - | - | Option to purchase common stock | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2020 | 30,000 | 320,787 (0%) | 0% | - | Common Stock, no par value | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 10,516 | 66,508 | - | - | Option to purchase common stock | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.34 per share. | 21 Dec 2020 | 10,516 | 326,155 (0%) | 0% | 1.3 | 14,091 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2020 | 7,652 | 318,503 (0%) | 0% | - | Common Stock, no par value | |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Sale of securities on an exchange or to another person at price $ 2.54 per share. | 21 Dec 2020 | 5,148 | 315,639 (0%) | 0% | 2.5 | 13,076 | Common Stock, no par value |
| Insight Molecular Diagnost... | Alfred D. Kingsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 5,909 | 302,811 (0%) | 0% | - | Common Stock |